TransDigm Announces Acquisition of the Electron Device Business of Communications & Power Industries (“CPI”)

CLEVELAND, Nov. 9, 2023 /PRNewswire/ — TransDigm Group Incorporated (NYSE: TDG) today announced it has entered into a definitive agreement to acquire the Electron Device Business (“the Company”) of Communications & Power Industries, a portfolio company of TJC, L.P., for approximately $1.385 billion in cash.   CPI’s Electron Device Business is a leading global manufacturer of… Continue reading TransDigm Announces Acquisition of the Electron Device Business of Communications & Power Industries (“CPI”)

Century Casinos, Inc. Announces Third Quarter 2023 Results

Record Quarterly Net Operating Revenue and Adjusted EBITDA** Completion of Rocky Gap Acquisition and Canada Real Estate Sale COLORADO SPRINGS, Colo., Nov. 9, 2023 /PRNewswire/ — Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) today announced its financial results for the three and nine months ended September 30, 2023. THIRD QUARTER 2023 HIGHLIGHTS* Compared to the three… Continue reading Century Casinos, Inc. Announces Third Quarter 2023 Results

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Holley Inc. f/k/a Empower Ltd. – (HLLY; HLLY.WT; EMPW; EMPW-WT)

NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Holley Inc. f/k/a Empower Ltd. (“Holley” or the “Company”) (NYSE: HLLY).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Holley and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Holley Inc. f/k/a Empower Ltd. – (HLLY; HLLY.WT; EMPW; EMPW-WT)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. – DMTK

NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DermTech, Inc. (“DermTech” or the “Company”) (NASDAQ: DMTK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether DermTech and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. – DMTK

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DISH Network Corporation – DISH

NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DISH Network Corporation (“DISH” or the “Company”) (NASDAQ: DISH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether DISH and certain of its officers and/or directors have engaged in securities fraud… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DISH Network Corporation – DISH

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRN

NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capstone Green Energy Corporation (“Capstone” or the “Company”) (NASDAQ: CGRN).  Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Capstone and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRN

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG

NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether SolarEdge and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. – BCLI

NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Brainstorm and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. – BCLI

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses in their Investment in Farfetch Limited of Class Action Lawsuit and Upcoming Deadline – FTCH

NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH) and certain officers. The class action, filed in the United States District Court for the District of Maryland, Southern Division, and docketed under 23-cv-02857, is on behalf of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses in their Investment in Farfetch Limited of Class Action Lawsuit and Upcoming Deadline – FTCH

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OTLK

NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and certain officers.   The class action, filed in the United States District Court for the District of New Jersey, and docketed under 23-cv-21862, is on behalf of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OTLK